Image

Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee

Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Primary objective: Description of ultrasound abnormalities seen in native septic arthritis of the knee during each visit.

Primary endpoint: Describe the ultrasound abnormalities observed on Day 0, Day 10, 6 weeks, 3 months, 6 months, during native septic arthritis of the knee.

Description

Secondary Objectives:

  1. Search for poor prognostic factors in native septic arthritis of the knee.
  2. To look for an association between initial sonographic factors and the use of joint lavage.
  3. Look for associations between sonographic signs and clinico-radio-biologic factors at each visit (D10, 6 weeks, 3 months and 6 months)

Eligibility

Inclusion Criteria:

  • Male or female of legal age
  • Bacteriologically proven native septic arthritis
  • Meets the definition of septic arthritis: Bacteriological documentation of joint puncture fluid-Native articulation
  • Free subject, without guardianship or trusteeship, or subordination
  • Non-opposition of the patient after clear and fair information about the study

Exclusion Criteria:

  • Presence of material in the affected joint
  • Arthritis with Mycobacterium Tuberculosis.
  • Patients benefiting from a reinforced protection, namely: minors, pregnant and/or breast-feeding women, persons deprived of liberty by a judicial or administrative decision, adults under legal protection

Study details
    Ultrasound Therapy; Complications
    Septic Arthritis
    Knee Arthritis

NCT04952220

Poitiers University Hospital

29 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.